[The Hwankyung Ilbo] The Ministry of Food and Drug Safety said that it plans to allow to import the hemp products approved by foreign countries for self-treatment for rare and incurable patients such as epilepsy, which have no alternative treatment method in Korea.
Currently, 'hemp' is strictly prohibited to handle, such as exporting, importing, manufacturing, buying and selling, except for the purpose of harvesting cannabis textile or seeds, conducting public service and academic research.
The Ministry of Food and Drug Safety will revise and supplement the legislation on hemp, which was initiated by the National Assembly last January, to promote the import and use of hemp-based medicines licensed overseas for self-treatment.
When the revised bill is implemented, it will be possible to import hemostatic pharmaceuticals (such as Sativex®) sold in the UK and France, or a recently licensed US-approved drug for epilepsy (Epidiolex®) for self-treatment.
However, even if it is derived from hemp, foods, hemp oil, and hemp extract that are not licensed as pharmaceuticals overseas are prohibited from being imported or used for self-treatment.
The Ministry of Food and Drug Safety said that it is collecting opinions from various sectors such as patient groups, doctors' groups, and civic groups on whether it is necessary to allow full acceptance of hemp pharmaceuticals.
조수빈 리포터 firstname.lastname@example.org
<저작권자 © 환경일보, 무단 전재 및 재배포 금지>